Search

Issue
Title
Authors
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G.P., Lopatin Y.M., Ametov A.S., Ageev F.T., Antsiferov M.B., Villevalde S.V., Vinogradova N.G., Galstyan G.R., Galyavich A.S., Gilyarevskiy S.R., Glezer M.G., Zhirov I.V., Ilyin M.V., Lebedeva A.I., Nedogoda S.M., Salukhov V.V., Tarlovskaya E.I., Tereshchenko S.N., Fomin I.V., Khalimov I.S., Khasanov N.R., Cherkashin D.V., Yakushin S.S.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M.V., Kotovskaya Y.V., Ivashkin V.T., Tkacheva O.N., Troshina E.A., Shestakova M.V., Breder V.V., Geyvandova N.I., Doshchitsin V.L., Dudinskaya E.N., Ershova E.V., Kodzoeva K.B., Komshilova K.A., Korochanskaya N.V., Mayorov A.Y., Mishina E.E., Nadinskaya M.Y., Nikitin I.G., Pogosova N.V., Tarzimanova A.I., Shamkhalova M.S.
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E.V., Dudnikova A.V.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M.L., Frolova N.F., Kim I.G., Ushakova A.I., Usatiuk S.S., Iskhakov R.T., Diakova E.N., Chervinko V.I., Volodina E.V., Tomilina N.A., Kryukov E.V.
Venous thromboembolic complications in patients with chronic kidney disease: prevalence and features of drug treatment
Dzhioeva O.N., Orlova A.A., Rogozhkina E.A., Drapkina O.M.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V.V., Pulin A.A., Mukhin N.A.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G.P., Tarlovskaia E.I., Koziolova N.A., Boldina M.V., Batiushin M.M., Ametov A.S., Arutiunov A.G., Belevskii A.S., Galstian G.R., Grigor’eva N.I., Dzhunusbekova G.A., Esaian A.M., Mal’chikova S.V., Mit’kovskaia N.P., Mkrtumian A.M., Orlova I.A., Petrova M.M., Rebrov A.P., Ruzanov D.I., Salukhov V.V., Sisakian A.S., Skibitskii V.V., Sugraliev A.B., Fomin I.V., Khalimov I.S., Chesnikova A.I., Shaposhnik I.I., Shestakova M.V.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S.V., Karovaikina E.A., Bulanov N.M., Moiseev A.S., Fomin V.V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E.V., Dmitriev V.A., Titov V.N.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N.V., Gulyaev S.V., Androsova T.V., Popova E.N., Gurova D.V., Novikov P.I., Milovanova L.Y., Moiseev S.V.
Polyvascular disease in patients with myocardial infarction and chronic kidney disease
Karetnikova V.N., Kalaeva V.V., Evseeva M.V., Gruzdeva O.V., Zykov M.V., Kashtalap V.V., Barbarash O.L.
Motivation for treatment in patients with chronic cardiorenal syndrome
Efremova E.V., Shutov A.M., Borodulina E.O.
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review)
Strizhakov L.A., Fomin V.V., Garipova R.V., Babanov S.A., Arkhipov E.V., Lebedeva M.V.
Specific features of cognitive impairments in patients with predialysis chronic kidney disease
Rogova I.V., Fomin V.V., Damulin I.V., Shashkova E.V.
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE
Smirnov A.V., Petrischev N.N., Mnuskina M.M., Panina I.Y., Pumyantsev A.S., Vasina E.Y., Achkasova V.V., Menshutina M.A.
The role of leptin, adiponectin and insulin-resistance markers in development of early stages of chronic kidney disease and atherosclerosis of carotid arteries in obese patients
Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A., Saginova E.A., Gallyamov M.G., Severova M.M., Surkova O.A., Fomin V.V., Ermakov N.V., Rodina A.V., Mukhin N.A.
The level of endothelin-1 and reactivity of skin microvessels in patients with early stages of chronic kidney disease
Smirnov A.V., Petrishchev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A., Smirnov A.V., Petrischev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A.
Chronic progressive nephropathies and modern lifestyle
Mukhin N.A., Balkarov I.M., Moiseev S.V., Fomin V.V., Lebedeva M.V., Krasnova E.A.
Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up
Zemlyanskaya O.A., Kropacheva E.S., Dobrovolsky A.B., Panchenko E.P.
Impact of smoking on kidney transplantation outcomes
Stolyar A.G., Tomilina N.A.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I.P., Mogutova P.A., Poteshkina N.G.
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Semenova R.I., Musina N.S.
Hyperuricemia as a component of cardiorenal syndrome
Mukhin N.A., Fomin V.V., Lebedeva M.V., Mukhin N.A., Fomin V.V., Lebedeva M.V.
Nephrological aspects of surgical weight correction in morbid obesity
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V., Struve A.V.
Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy
Murkamilov I.T., Sabirov I.S., Fomin V.V., Yusupov F.A.
Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
Vasilyeva M.P., Rudenko T.E., Kutyrina I.M., Solomakhina N.I.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I.B., Stavrovskaia E.V.
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
Milovanov Y.S., Milovanova L.Y.
PERSONIFICATED MEDICINE IN CLINICAL NEPHROLOGY
Mukhin N.A., Fomin V.V.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I.I., Severina A.S., Shamkhalova M.S., Shestakova M.V.
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
Milovanova L.Y., Milovanov Y.S., Kudryavtseva D.V., Markina M.M., Milovanova S.Y., Kozlovskaya L.V., Lebedeva M.V., Beketov V.D., Moiseev S.V., Mukhin N.A., Fomin V.V., Svistunov A.A.
Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
Dzgoeva F.U., Gatagonova T.M., Bestaeva T.L., Sopoev M.I., Bazaeva B.G., Khamitsaeva O.V.
The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease
Mikhailova N.A.
Diabetes epidemiology in Russia: what has changed over the decade?
Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Dedov I.I.
Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
Rudenko T.E., Kamyshova E.S., Vasilyeva M.P., Bobkova I.N., Solomakhina N.I., Shvetsov M.Y.
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease
Milovanova L.I., Dobrosmyslov I.A., Milovanov I.S.
Risk factors for cardiovascular system damage in chronic kidney disease
Kutyrina I.M., Rudenko T.E., Savel'eva S.A., Shvetsov M.I., Vasil'eva M.P.
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study
Batyushin M.M.
Normoalbuminuric chronic kidney disease in diabetes
Klimontov V.V., Korbut A.I.
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease
Mukhin N.A., Milovanov Y.S., Kozlovskaya L.V., Dobrosmyslov I.A., Milovanova L.Y.
Nonglycemic effects of incretins in patients with long-term type 1 diabetes mellitus and chronic kidney disease
Arutyunova M.S., Glazunova A.M., Mikhaleva O.V., Zuraeva Z.T., Martynov S.A., Klefortova I.I., Manchenko O.V., Ulyanova I.N., Ilyin A.V., Shamkhalova M.S., Shestakova M.V.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F.U., Sopoev M.Y., Gatagonova T.M., Bestaeva T.L., Khamitsaeva O.V.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A.A., Kustova T.I., Fomin V.V., Mukhin N.A.
Circulating microRNAs as potential biomarkers of chronic kidney disease
Aitbaev K.A., Murkamilov I.T., Fomin V.V.
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Bayzhigitova A.A.
Hyperuricemia and the problem of chronic kidney disease
Shcherbak A.V., Kozlovskaia L.V., Bobkova I.N., Balkarov I.M., Lebedeva M.V., Stakhova T.I.
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity
Galliamov M.G., Saginova E.A., Severova M.M., Samokhodskaia L.M., Krasnova T.N., Sholomova V.I., Sorokin I.D., Mukhin N.A.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.Y.
1 - 50 of 50 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies